StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
GOSS

Gossamer Bio, Inc.

GOSS Nasdaq Pharmaceutical Preparations EDGAR ↗
$0.17
-0.00 -2.47%

Key statistics

from XBRL data in SEC filings
Market cap
$40.7M
Revenue (TTM)
$55.5M
Net income (TTM)
-$180M
EPS (TTM)
$-0.79
P/E ratio
Dividend yield
Free cash flow
-$171M
Cash
$41.0M
Total assets
$129M
Gross margin
52-week range
$0.11 – $3.87

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Entered a material agreement; Terminated a material agreement; Results of operations (earnings release); Regulation FD disclosure; Other events Jul 27, 2026 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jul 15, 2026 8-K Regulation FD disclosure Jul 1, 2026 8-K Regulation FD disclosure Jun 17, 2026 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure Jun 5, 2026 8-K Shareholder vote results Jun 5, 2026 8-K Other events Jun 2, 2026 8-K Entered a material agreement; Results of operations (earnings release); Director or officer change; Regulation FD disclosure; Other events May 18, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Delisting notice or listing-rule failure Apr 9, 2026 8-K Results of operations (earnings release) Mar 17, 2026 10-K Fiscal year ended 2025-12-31 Mar 17, 2026 8-K Other events Feb 23, 2026 8-K Results of operations (earnings release) Nov 5, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Unregistered sale of equity Sep 25, 2025 8-K Results of operations (earnings release) Aug 5, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Director or officer change; Shareholder vote results Jun 25, 2025 8-K Regulation FD disclosure; Other events Jun 16, 2025 8-K Results of operations (earnings release) May 15, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release) Mar 13, 2025 10-K Fiscal year ended 2024-12-31 Mar 13, 2025 8-K Other events Feb 19, 2025 8-K Results of operations (earnings release) Nov 7, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Delisting notice or listing-rule failure Sep 13, 2024 8-K Results of operations (earnings release) Aug 12, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Other events Jul 18, 2024 8-K Shareholder vote results Jun 10, 2024 8-K Delisting notice or listing-rule failure May 24, 2024 8-K Results of operations (earnings release) May 7, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Entered a material agreement; Terminated a material agreement; Unregistered sale of equity; Other events May 6, 2024 8-K Director or officer change Mar 12, 2024 10-K Fiscal year ended 2023-12-31 Mar 5, 2024 8-K Results of operations (earnings release) Mar 5, 2024 8-K Other events Mar 4, 2024